Nippon India Pharma Fund - Direct (G) vs SBI Focused Fund - Direct (G)
Nippon India Pharma Fund - Direct (G) vs SBI Focused Fund - Direct (G)
Nippon India Pharma Fund - Direct (G)
10.69%
SBI Focused Fund - Direct (G)
12.36%
Graph not available
About Fund
Deutsche Bank AG
Karvy Computershare Pvt. Ltd.
Citi Bank HDFC Bank Ltd. Stock Holding Corporation of India
Computer Age Management Services Pvt. Ltd Computronics Financial Services India Ltd Datamatics Financial Software Services Ltd
Fund Details
Very High Risk
5000
8365.40
1.12
613.0786
January 1, 2013
1
Very High Risk
5000
46041.95
1.12
429.1101
January 1, 2013
0
Very High Risk
5000
8365.40
1.12
613.0786
January 1, 2013
1
Very High Risk
5000
46041.95
1.12
429.1101
January 1, 2013
0
14.76 %
25.19 %
10.69 %
15.79 %
18.21 %
12.36 %
Sailesh Raj Bhan
MBA (Finance), CFA.
Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.
R Srinivasan
M.Com., MFM from University of Bombay.
Prior to joining SBI he has worked with Principal PNB AMC, Oppenheimer & Co, Indosuez WI Carr and Motilal Oswal.
Get your FAQs right
When comparing Nippon India Pharma Fund - Direct (G) vs SBI Focused Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both Nippon India Pharma Fund - Direct (G) and SBI Focused Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing Nippon India Pharma Fund - Direct (G) and SBI Focused Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between Nippon India Pharma Fund - Direct (G) and SBI Focused Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare Nippon India Pharma Fund - Direct (G) and SBI Focused Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.
